← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2015Last known activity
Dec 20, 2021
Timeline
2000s
- Feb 7, 2002
Nanjing Yoko Biomedical Co., Ltd.— Founded
Drugs by trial phase (13 distinct, 9 trials)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT05588531Lead sponsorPhase 1Dec 20, 2021
- NCT04984577Lead sponsorPhase 2Sep 30, 2021
- NCT04670809Lead sponsorPhase 3Jul 27, 2020
- NCT04219865Lead sponsorPhase 1May 30, 2019
- NCT04218513Lead sponsorPhase 1May 7, 2019
- NCT03650933Lead sponsorPhase 3Oct 31, 2018
- NCT04205565Lead sponsorPhase 2Jul 26, 2017
- NCT03003039Lead sponsorPhase 1Oct 1, 2016
- NCT02717741Lead sponsorPhase 1May 1, 2015
Details
- Founded
- Nanjing, CN Feb 7, 2002
- Last known activity
- Dec 20, 2021